By Linda Chiem ( January 14, 2015, 1:17 PM EST) -- Private equity-backed biotech Bellerophon Therapeutics LLC, which is developing therapies and medical devices for cardiopulmonary diseases, filed on Tuesday for an up to $69 million initial public offering as it ramps up research and development and completes clinical trials....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.